Literature DB >> 2840111

Respiratory health in chrysotile asbestos miners in British Columbia: a longitudinal study.

D A Enarson1, V Embree, L MacLean, S Grzybowski.   

Abstract

A respiratory survey was undertaken in chrysotile asbestos miners in British Columbia consisting of a questionnaire, spirometry, chest radiography, and physical examination. The tests were performed in 1977 and again in 1983. The population groups studied included 63 "exposed" (working in the plant more than nine years), 52 "controls" (working in the plant less than five years), and 38 residents of the village at the minesite. A subset of 39 was identified with high exposure (worked in the mill more than five years). Measured levels of environmental particulates were similar over the entire period of operation of the plant (1.4 to 14.0 million particles per cubic foot and 0.7-88.0 fibres/cc in the mill; 0.2 to 2.7 mpcf and 0.6 to 9.3 f/cc in the mine). The exposed groups were more likely to report cough and breathlessness than the two other groups and were also more likely to have abnormal FVC and chest x ray films (the latter not significant, p greater than 0.05) and to be more likely to have a combination of these abnormalities. There was no trend to progression in the combination of abnormalities associated with exposure on follow up. The heavily exposed group showed a significantly worse trend in FVC. This adverse trend was confined to those with initial abnormalities. Tobacco smoking did not increase the trend to progression in this group.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840111      PMCID: PMC1009629          DOI: 10.1136/oem.45.7.459

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  9 in total

Review 1.  Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice.

Authors:  M R Becklake
Journal:  Am Rev Respir Dis       Date:  1976-07

2.  Lung asbestos content in long-term residents of a chrysotile mining town.

Authors:  A Churg
Journal:  Am Rev Respir Dis       Date:  1986-07

3.  The health of chrysotile asbestos mine and mill workers of Quebec.

Authors:  J C McDonald; M R Becklake; G W Gibbs; A D McDonald; C E Rossiter
Journal:  Arch Environ Health       Date:  1974-02

4.  Radiographic changes in chrysotile asbestos mine and mill workers of Quebec.

Authors:  C E Rossiter; L J Bristol; P H Cartier; J G Gilson; T R Grainger; G K Sluis-Cremer; J C McDonald
Journal:  Arch Environ Health       Date:  1972-06

5.  Lung function in chrysotile asbestos mine and mill workers of Quebec.

Authors:  M R Becklake; G Fournier-Massey; C E Rossiter; J C McDonald
Journal:  Arch Environ Health       Date:  1972-06

6.  Spirometric standards for healthy nonsmoking adults.

Authors:  J F Morris; A Koski; L C Johnson
Journal:  Am Rev Respir Dis       Date:  1971-01

7.  Radiographic search for asbestos-related disease in a naval shipyard.

Authors:  J S Felton
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

8.  Risk of asbestosis in crocidolite and amosite mines in South Africa.

Authors:  L M Irwig; R S du Toit; G K Sluis-Cremer; A Solomon; R G Thomas; P P Hamel; I Webster; T Hastie
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

9.  Follow-up respiratory measurements in Quebec chrysotile asbestos miners and millers.

Authors:  M R Becklake; D Thomas; F Liddell; J C McDonald
Journal:  Scand J Work Environ Health       Date:  1982       Impact factor: 5.024

  9 in total
  2 in total

1.  Non-malignant consequences of decreasing asbestos exposure in the Brazil chrysotile mines and mills.

Authors:  E Bagatin; J A Neder; L E Nery; M Terra-Filho; J Kavakama; A Castelo; V Capelozzi; A Sette; S Kitamura; M Favero; D C Moreira-Filho; R Tavares; C Peres; M R Becklake
Journal:  Occup Environ Med       Date:  2005-06       Impact factor: 4.402

2.  Descriptive analysis of the respiratory health status of persons exposed to Libby amphibole asbestos.

Authors:  Charlene A Winters; Wade G Hill; Kimberly Rowse; Brad Black; Sandra W Kuntz; Clarann Weinert
Journal:  BMJ Open       Date:  2012-11-21       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.